openPR Logo
Press release

Global Lower Respiratory Tract Infection Treatment Market Industry Analysis and Research Report 2017-2025

10-16-2017 11:17 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Lower Respiratory Tract Infection Treatment Market

The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. Many microorganisms can cause the infection such as virus viz. adenoviruses, coronaviruses, parainfluenza virus, rhinoviruses etc and bacteria viz. Bordetella pertussis, Chlamydophila pneumoniae and Mycoplasma pneumoniae etc. Lower respiratory tract infection are leading cause of morbidity and mortality in children and adults worldwide.

The global lower respiratory tract infection market is anticipated to witness lucrative growth due to increasing prevalence of lung diseases, surge in geriatric population, rise in risk of pneumonia in children, etc. According to World Health Organization (WHO), Respiratory syncytial virus (RSV) is responsible for 30 million lower respiratory tract infection cases in children worldwide, the prevalence of such viral diseases will drive the growth of the global market through 2027. Furthermore, the newer advances in treatment and the facilities, treatment with lower potential side effects, etc. will propel the growth of the global market during the forecast period. Inappropriate and lack of in-vitro facilities for conducting research studies for novel treatment alternatives is the factor that can hamper the growth of the global lower respiratory tract infection market during the forecast period.

Request for Report TOC @ https://www.persistencemarketresearch.com/toc/14866

On the basis of the treatment, the global market is segmented into supportive care, hospital care, drugs and vaccines. The drugs segment can be further divided into antibiotics such as penicillin, amoxicillin, vancomycin, cephalosporin and others. The drug segment is anticipated to hold the largest share of the global market, in terms of revenue owing to factors like quicker onset of action, faster response, high potency and better efficiency etc. On the basis of transmission, the global market is divided into hospital acquired, ventilator acquired and community acquired. The hospital acquired segment is anticipated to hold the share of the global market due to increase in nosocomial infection owing to MDR (multiple drug resistance) microorganism infection in the hospitals.

Based on the end user, the global lower respiratory tract infection market is segmented into hospitals and clinics, and ambulatory surgical centers. Hospitals are expected to hold the maximum share of the global market since advance facilities from diagnosis to treatment are provided under a roof.

On the basis of geography, the global lower respiratory tract infection market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America accounts for the major market share due to rise in geriatric population, increase in multi-drug resistance bacterial infection among children and immune-compromised adults. Furthermore, government initiatives towards treatment of the infection will drive the growth of the lower respiratory tract infection treatment market in the region.

Asia Pacific market is anticipated to be the fastest growing market due to factors such as rise in patient awareness, improved health care infrastructure and facilities, high disposable income, prevalence of unhealthy lifestyle etc.

Request for Report Sample @ https://www.persistencemarketresearch.com/samples/14866

Major players operating in the global lower respiratory tract infection market include Sanofi Pasteur SA, AstraZeneca, Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc. etc among others worldwide. To maintain a significant position in the global market, companies focus on strategies like mergers and acquisitions, treatment efficiency and efficacy, cost friendly services etc.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Lower Respiratory Tract Infection Treatment Market Industry Analysis and Research Report 2017-2025 here

News-ID: 774472 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Respiratory

Global Respiratory Devices and Equipment (Therapeutic) Market | Global Respirato …
The respiratory devices & equipment therapeutic market comprises of the sales of respiratory devices & equipment used for treating the patients with acute or chronic respiratory disorders for instance chronic obstructive pulmonary disease (COPD), sleep disorders, chronic bronchitis, asthma, etc. The market includes sales of respiratory monitoring devices establishments mainly engaged in the manufacturing of oxygen concentrators, nebulizers, humidifiers, positive airway pressure devices, ventilators, capnographs, and gas analyzers. According to study,
Global Respiratory Monitoring Devices Market | Global Respiratory Monitoring Dev …
Respiration is a unique process of human lives, which jumps at the time of birth and lasts till decease. A healthy human body is skilled of respiration process for numerous years but, due to rising levels of pollution in urban cities and lives concerning tobacco smoking, clogging of airways and other structures of the lung is turning into a common concern across the globe. The respiratory monitoring devices market comprises
Middle East and Africa Respiratory InhalerMarket- AstraZeneca is advancing clini …
Recent Developments AstraZeneca is multinational pharmaceutical and Biopharmaceutical Company. The company provides innovative medicines which are used by millions of people worldwide. AstraZeneca reduces the risk of death and disease progression. The company primarily focuses on development and discovery of cardiovascular, respiratory and inflammation, oncology and infectious disease. To know more:https://www.marketdataforecast.com/market-reports/middle-east-and-africa-respiratory-inhaler-market-6377/ Market Segmentations: Market Data Forecast published a report named Middle East and Africa Respiratory InhalerMarket. It is estimated to grow at a robust
Respiratory Devices Analysis Report of Respiratory Devices in Global Market 2018 …
- Global Respiratory Devices Market: Overview Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, respiratory devices are used to deliver medicines to treat several respiratory diseases. Moreover, these devices are used to diagnose respiratory problems in patients. Increase in incidence of COPD and sleep apnea, strategic alliance between key players, and rise in government expenditure are the major factors projected to propel the
Neonatal Respiratory Distress Syndrome Market is driven by high prevalence of re …
Neonatal respiratory distress syndrome, also referred to as infant respiratory distress syndrome is characterized by a particular condition often observed in premature babies, usually born about six weeks before their due dates. During this condition, lungs of the premature infants lose the ability to produce enough surfactants in order to provide oxygen to the body. Surfactants are liquids made up of fat and proteins and it helps the lungs to
Global Respiratory Monitoring Devices Market to Benefit from Increasing Prevalen …
Respiratory disease is a serious public health concern due to rapidly growing number of smokers worldwide. Governments are implementing various health schemes to reduce the death rate caused due to respiratory disease and disorders. Respiratory disease is a medical condition that affects the structure and organs (respiratory system) associated with respiration or breathing. Rise in respiratory diseases such as chronic obstructive pulmonary diseases, asthma, and lung cancer has triggered the growth